共 46 条
[21]
Hart, Sherman, The diagnosis of multiple sclerosis, JAMA, 247, pp. 498-503, (1982)
[22]
Tourtellotte, Cerebrospinal fluid in multiple sclerosis, Handbook of clinical neurology, 9, pp. 82-324, (1970)
[23]
Vatassery, Chiang, Tourje, Relationship of total lipids, proteins and albumin in human cerebrospinal fluid with age, Biochem Med, 27, pp. 161-167, (1982)
[24]
Tibbling, Link, Ohman, Principles of albumin and IgG analyses in neurological disorders I Establishment of reference values, Scandinavian Journal of Clinical and Laboratory Investigation, 37, pp. 90-385, (1977)
[25]
Noseworthy, Wonnacott, Paty, Feasby, Ebers, Multiple sclerosis after age 50, Neurology, 33, 12, pp. 1537-1544, (1983)
[26]
Kappos, Stadt, Hennes, Rohrbach, Keil, Gd∗∗∗-enhanced MRI in multiple sclerosis: evaluation of different disease courses, disease activity and treatment efficacy, Second European congress of NMR in medicine and biology, 124, (1988)
[27]
Walker, Thompson, Mcdonald, Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features, J Neurol, 232, pp. 250-259, (1985)
[28]
Livrea, Simone, Trojano, Pisicchio, Logroscino, Rosato, Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis, Riv Neurol, 57, pp. 96-189, (1987)
[29]
Gallo, Bracco, Tavolato, Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG, J Neurol Sci, 84, pp. 87-93, (1988)
[30]
Gado, Phelps, Coleman, An extravascular component of contrast enhancement in cranial computed tomography: II. contrast enhancement and the blood-tissue barrier, Radiology, 117, pp. 595-597, (1975)